Suppr超能文献

基于药物浓度阈值的不依从性检测的受试者工作特征框架-在精神分裂症患者模拟利培酮数据中的应用。

A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic Patients.

机构信息

Janssen Research & Development, Clinical Pharmacology & Pharmacometrics, Beerse, Belgium.

Janssen Research & Development, Quantitative Sciences Consulting, Beerse, Belgium.

出版信息

AAPS J. 2019 Mar 14;21(3):40. doi: 10.1208/s12248-019-0299-9.

Abstract

Non-adherence to antipsychotic medication is a primary factor in disease relapse in schizophrenic patients. We sought to evaluate if plasma concentrations of the antipsychotic risperidone can be used as a predictor of treatment adherence and to identify the optimal plasma concentration threshold to reliably distinguish between adherent and non-adherent patients. A population pharmacokinetic model was used to simulate plasma risperidone steady-state trough concentrations in 1000 virtual patients, where 60% of the patients were 100% adherent to their medication, while 40% of the patients were non-adherent to their medication. The probability of adherence was assessed by receiver operating characteristic (ROC) analysis on C. The area under the ROC curve (AUC) was used to identify the optimal C threshold. Single vs multiple C at steady state was also evaluated. After a single risperidone C measurement, the AUC (95% CI) was estimated to be 0.71 (0.69-0.72) and the optimal C threshold accounting for the lowest number of adherent and non-adherent misclassifications was estimated to be 11.9 ng/mL. After multiple C measurements, the AUC (95% CI) increased up to 0.85 (0.84-0.87) for three C measurements. The optimal probability threshold to reliably discriminate between adherent and non-adherent patients was estimated to be 0.51. Using this model which is reflective of typical adherence to antipsychotic medication, we found that three consecutive steady-state C measurements are needed for an accurate and precise diagnostic test to discriminate between patients who are adherent or non-adherent to treatment.

摘要

抗精神病药物治疗不依从是精神分裂症患者疾病复发的主要因素。我们旨在评估抗精神病药利培酮的血浆浓度是否可用作治疗依从性的预测指标,并确定可靠地区分依从性和非依从性患者的最佳血浆浓度阈值。使用群体药代动力学模型模拟了 1000 名虚拟患者的利培酮稳态谷浓度,其中 60%的患者对其药物治疗 100%依从,而 40%的患者不依从其药物治疗。通过 C 值的接收者操作特征 (ROC) 分析评估依从性的概率。ROC 曲线下面积 (AUC) 用于确定最佳 C 值阈值。还评估了稳态下的单次与多次 C 值。单次利培酮 C 值测量后,AUC(95%CI)估计为 0.71(0.69-0.72),且估计能使最少数量的依从性和非依从性误分类的最低 C 值阈值为 11.9ng/mL。多次 C 值测量后,AUC(95%CI)增加至 0.85(0.84-0.87),进行三次 C 值测量。估计可靠地区分依从性和非依从性患者的最佳概率阈值为 0.51。使用反映典型抗精神病药物治疗依从性的此模型,我们发现需要进行三次连续的稳态 C 值测量,以进行准确且精密的诊断试验来区分依从性和非依从性患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验